These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 21558397)
1. Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened. Tang T; Tang JY; Li D; Reich M; Callahan CA; Fu L; Yauch RL; Wang F; Kotkow K; Chang KS; Shpall E; Wu A; Rubin LL; Marsters JC; Epstein EH; Caro I; de Sauvage FJ Clin Cancer Res; 2011 May; 17(10):3378-87. PubMed ID: 21558397 [TBL] [Abstract][Full Text] [Related]
2. Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor. Skvara H; Kalthoff F; Meingassner JG; Wolff-Winiski B; Aschauer H; Kelleher JF; Wu X; Pan S; Mickel L; Schuster C; Stary G; Jalili A; David OJ; Emotte C; Antunes AM; Rose K; Decker J; Carlson I; Gardner H; Stuetz A; Bertolino AP; Stingl G; De Rie MA J Invest Dermatol; 2011 Aug; 131(8):1735-44. PubMed ID: 21430703 [TBL] [Abstract][Full Text] [Related]
3. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Williams JA; Guicherit OM; Zaharian BI; Xu Y; Chai L; Wichterle H; Kon C; Gatchalian C; Porter JA; Rubin LL; Wang FY Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4616-21. PubMed ID: 12679522 [TBL] [Abstract][Full Text] [Related]
4. SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas. Kim AL; Back JH; Chaudhary SC; Zhu Y; Athar M; Bickers DR J Invest Dermatol; 2018 Aug; 138(8):1716-1725. PubMed ID: 29550418 [TBL] [Abstract][Full Text] [Related]
5. Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin. Danhof R; Lewis K; Brown M Am J Clin Dermatol; 2018 Apr; 19(2):195-207. PubMed ID: 28887802 [TBL] [Abstract][Full Text] [Related]
6. Interaction of hedgehog and vitamin D signaling pathways in basal cell carcinomas. Albert B; Hahn H Adv Exp Med Biol; 2014; 810():329-41. PubMed ID: 25207374 [TBL] [Abstract][Full Text] [Related]
7. Hedgehog Pathway Inhibition. Sekulic A; Von Hoff D Cell; 2016 Feb; 164(5):831. PubMed ID: 26919418 [TBL] [Abstract][Full Text] [Related]
8. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. Vidal D; Matías-Guiu X; Alomar A Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339 [TBL] [Abstract][Full Text] [Related]
9. Sonidegib phosphate: new approval for basal cell carcinoma. Tibes R Drugs Today (Barc); 2016 May; 52(5):295-303. PubMed ID: 27376162 [TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations. Grachtchouk M; Pero J; Yang SH; Ermilov AN; Michael LE; Wang A; Wilbert D; Patel RM; Ferris J; Diener J; Allen M; Lim S; Syu LJ; Verhaegen M; Dlugosz AA J Clin Invest; 2011 May; 121(5):1768-81. PubMed ID: 21519145 [TBL] [Abstract][Full Text] [Related]
11. Emerging drugs and combination strategies for basal cell carcinoma. Dreier J; Dummer R; Felderer L; Nägeli M; Gobbi S; Kunstfeld R Expert Opin Emerg Drugs; 2014 Sep; 19(3):353-65. PubMed ID: 24773312 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial. Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385 [TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma and the carcinogenic role of aberrant Hedgehog signaling. Saran A Future Oncol; 2010 Jun; 6(6):1003-14. PubMed ID: 20528237 [TBL] [Abstract][Full Text] [Related]
15. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Hutchin ME; Kariapper MS; Grachtchouk M; Wang A; Wei L; Cummings D; Liu J; Michael LE; Glick A; Dlugosz AA Genes Dev; 2005 Jan; 19(2):214-23. PubMed ID: 15625189 [TBL] [Abstract][Full Text] [Related]
16. Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity. Villani RM; Adolphe C; Palmer J; Waters MJ; Wainwright BJ Cancer Prev Res (Phila); 2010 Oct; 3(10):1222-34. PubMed ID: 20858761 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature. Drehs MM; Cook-Bolden F; Tanzi EL; Weinberg JM Dermatol Surg; 2002 May; 28(5):427-9. PubMed ID: 12030878 [TBL] [Abstract][Full Text] [Related]
18. Hedgehog signaling pathway as a target for therapeutic intervention in basal cell carcinoma. Williams JA Drug News Perspect; 2003 Dec; 16(10):657-62. PubMed ID: 14747845 [TBL] [Abstract][Full Text] [Related]